Microelectronic Medical Implants: Products, Technologies & Opportunities

Published - May 2016| Analyst - Andrew McWilliams| Code - HLC016E
Microelectronic Medical Implants: Products, Technologies & Opportunities
Single User License: $2750 Member Price: FREE

Report Highlights

The global market for microelectronic medical implants should reach over $37.6 billion in 2021 from over $24.6 billion in 2016 at a compound annual growth rate (CAGR) of 8.8% from 2016 to 2021.

Report Includes

  • An overview of the global markets and technologies for microelectronic medical implants.
  • An analysis of global market trends, with data from 2015, 2016 and projections of compound annual growth rates (CAGRs) through 2021.
  • Major implant types and applications, both commercial and developmental.
  • Global market size and segmentation, including historical data on sales by application and implant type.
  • Market drivers and constraints.
  • A look at industry structure, competition and market shares.
  • Factors that may influence the long-term market for microelectronic implants.
  • Profiles of major players in the industry.

Report Scope

This report covers microelectronic devices designed to operate within the human body, including:

  • Pacemakers. 
  • Implantable cardioverter defibrillators (ICDs). 
  • Implantable loop recorders.
  • Ventricular assist blood pumps.
  • Artificial hearts.
  • Neurostimulator devices used to combat pain or to treat epilepsy, Parkinson’s disease and incontinence. 
  • Spinal fusion stimulators.
  • Implanted drug infusion pumps.
  • Implanted monitoring devices.
  • Cochlear implants to treat the profoundly deaf. 
  • Retinal implants being developed to treat the blind.

Analyst Credentials

Andrew McWilliams spent more than 25 years as a consultant with Ernst & Young, McKinsey & Company and A.T. Kearny focused on manufacturing before segueing into research analysis. He has been covering myriad technology categories for BCC Research for more than 15 years. McWilliams has a BA from Princeton University and an MA from Harvard University. He has worked in more than 40 countries and he resides in the greater Boston area.

Select reports include:

Table of Contents & Pricing

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Note: Reports are discounted or included with certain Memberships. See Membership Options.
 
Published - May-2011| Analyst - Andrew McWilliams| Code - HLC016D

Report Highlights

The global market for microelectronic medical implants, accessories, and supplies was worth an estimated $15.4 billion in 2010. The market is projected to grow to $16.3 billion in 2011 and $24.8 billion in 2016, a compound annual growth rate (CAGR) of 8.8%, between 2011 and 2016. 

Published - Jun-2007| Analyst - Andrew McWilliams| Code - HLC016C

Report Highlights

  • The global market for microelectronic medical implants was worth an estimated $11.7 billion in 2006. The market is projected to grow to $12.6 billion in 2007 and $22.1 billion in 2012 at a CAGR of 11.9% from 2007 to 2012.
  • Cardiac implants were by far the largest market segment in 2006, accounting for more than three-quarters of total implant sales. Neurostimulators were the second largest market segment, with about 9% of the market, followed by accessories such as leads and electrodes, with a 7% market share. executive summary (Continued)
  • However, the market for neurostimulators is projected to grow over twice as fast as the market for cardiac implants from 2007 to 2012, that is, at a CAGR of 20% vs. 10% respectively.
Published - Sep-2004| Analyst - Andrew McWilliams| Code - HLC016B

Report Highlights

  • The global market for microelectronic medical implants is projected to be $11.9 billion in 2004 and to rise at an average annual growth rate (AAGR) of 22.1% to $32.3 billion in 2009.
  • Cardiac implants by far were the largest market segment in 2003, with sales of $7.2 billion, or more than three-quarters of total sales.
  • Neurostimulators were the second largest market segment, with sales of $944 million, but are projected to grow at an AAGR of 39.7%, more than double that of cardiac implants (18.4%).
  • The AAGR for accessories and supplies (27.5%) also is expected to outstrip growth of the market as a whole. The slowest-growing market segments likely will be spinal fusion stimulators and implantable drug pumps.
  • Eye implants are unlikely to see any commercial sales before 2009.

CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

Contact Us
RELATED REPORTS
Share This Report